Request for Covid-19 Impact Assessment of this Report
The United States Secukinumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Secukinumab market, reaching US$ million by the year 2028. As for the Europe Secukinumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Secukinumab players cover Carbosynth, TargetMol Chemicals, Changzhou Chenhong Biotechnology, and DC Chemicals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Secukinumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Patent
Generic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chemical
Pharmaceutical
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Carbosynth
TargetMol Chemicals
Changzhou Chenhong Biotechnology
DC Chemicals
Huatesheng Biotechnology
Hubei Guangao Biotechnology
Hubei Kele Fine Chemical
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Minkai Biotechnology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Topule Biopharmaceutical
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Secukinumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Secukinumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Secukinumab by Country/Region, 2017, 2022 & 2028
2.2 Secukinumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Secukinumab Sales by Type
2.3.1 Global Secukinumab Sales Market Share by Type (2017-2022)
2.3.2 Global Secukinumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Secukinumab Sale Price by Type (2017-2022)
2.4 Secukinumab Segment by Application
2.4.1 Chemical
2.4.2 Pharmaceutical
2.5 Secukinumab Sales by Application
2.5.1 Global Secukinumab Sale Market Share by Application (2017-2022)
2.5.2 Global Secukinumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Secukinumab Sale Price by Application (2017-2022)
3 Global Secukinumab by Company
3.1 Global Secukinumab Breakdown Data by Company
3.1.1 Global Secukinumab Annual Sales by Company (2020-2022)
3.1.2 Global Secukinumab Sales Market Share by Company (2020-2022)
3.2 Global Secukinumab Annual Revenue by Company (2020-2022)
3.2.1 Global Secukinumab Revenue by Company (2020-2022)
3.2.2 Global Secukinumab Revenue Market Share by Company (2020-2022)
3.3 Global Secukinumab Sale Price by Company
3.4 Key Manufacturers Secukinumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Secukinumab Product Location Distribution
3.4.2 Players Secukinumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Secukinumab by Geographic Region
4.1 World Historic Secukinumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Secukinumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Secukinumab Annual Revenue by Geographic Region
4.2 World Historic Secukinumab Market Size by Country/Region (2017-2022)
4.2.1 Global Secukinumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Secukinumab Annual Revenue by Country/Region
4.3 Americas Secukinumab Sales Growth
4.4 APAC Secukinumab Sales Growth
4.5 Europe Secukinumab Sales Growth
4.6 Middle East & Africa Secukinumab Sales Growth
5 Americas
5.1 Americas Secukinumab Sales by Country
5.1.1 Americas Secukinumab Sales by Country (2017-2022)
5.1.2 Americas Secukinumab Revenue by Country (2017-2022)
5.2 Americas Secukinumab Sales by Type
5.3 Americas Secukinumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Secukinumab Sales by Region
6.1.1 APAC Secukinumab Sales by Region (2017-2022)
6.1.2 APAC Secukinumab Revenue by Region (2017-2022)
6.2 APAC Secukinumab Sales by Type
6.3 APAC Secukinumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Secukinumab by Country
7.1.1 Europe Secukinumab Sales by Country (2017-2022)
7.1.2 Europe Secukinumab Revenue by Country (2017-2022)
7.2 Europe Secukinumab Sales by Type
7.3 Europe Secukinumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Secukinumab by Country
8.1.1 Middle East & Africa Secukinumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Secukinumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Secukinumab Sales by Type
8.3 Middle East & Africa Secukinumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Secukinumab
10.3 Manufacturing Process Analysis of Secukinumab
10.4 Industry Chain Structure of Secukinumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Secukinumab Distributors
11.3 Secukinumab Customer
12 World Forecast Review for Secukinumab by Geographic Region
12.1 Global Secukinumab Market Size Forecast by Region
12.1.1 Global Secukinumab Forecast by Region (2023-2028)
12.1.2 Global Secukinumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Secukinumab Forecast by Type
12.7 Global Secukinumab Forecast by Application
13 Key Players Analysis
13.1 Carbosynth
13.1.1 Carbosynth Company Information
13.1.2 Carbosynth Secukinumab Product Offered
13.1.3 Carbosynth Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Carbosynth Main Business Overview
13.1.5 Carbosynth Latest Developments
13.2 TargetMol Chemicals
13.2.1 TargetMol Chemicals Company Information
13.2.2 TargetMol Chemicals Secukinumab Product Offered
13.2.3 TargetMol Chemicals Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 TargetMol Chemicals Main Business Overview
13.2.5 TargetMol Chemicals Latest Developments
13.3 Changzhou Chenhong Biotechnology
13.3.1 Changzhou Chenhong Biotechnology Company Information
13.3.2 Changzhou Chenhong Biotechnology Secukinumab Product Offered
13.3.3 Changzhou Chenhong Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Changzhou Chenhong Biotechnology Main Business Overview
13.3.5 Changzhou Chenhong Biotechnology Latest Developments
13.4 DC Chemicals
13.4.1 DC Chemicals Company Information
13.4.2 DC Chemicals Secukinumab Product Offered
13.4.3 DC Chemicals Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 DC Chemicals Main Business Overview
13.4.5 DC Chemicals Latest Developments
13.5 Huatesheng Biotechnology
13.5.1 Huatesheng Biotechnology Company Information
13.5.2 Huatesheng Biotechnology Secukinumab Product Offered
13.5.3 Huatesheng Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Huatesheng Biotechnology Main Business Overview
13.5.5 Huatesheng Biotechnology Latest Developments
13.6 Hubei Guangao Biotechnology
13.6.1 Hubei Guangao Biotechnology Company Information
13.6.2 Hubei Guangao Biotechnology Secukinumab Product Offered
13.6.3 Hubei Guangao Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hubei Guangao Biotechnology Main Business Overview
13.6.5 Hubei Guangao Biotechnology Latest Developments
13.7 Hubei Kele Fine Chemical
13.7.1 Hubei Kele Fine Chemical Company Information
13.7.2 Hubei Kele Fine Chemical Secukinumab Product Offered
13.7.3 Hubei Kele Fine Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hubei Kele Fine Chemical Main Business Overview
13.7.5 Hubei Kele Fine Chemical Latest Developments
13.8 Hubei Widely Chemical Technology
13.8.1 Hubei Widely Chemical Technology Company Information
13.8.2 Hubei Widely Chemical Technology Secukinumab Product Offered
13.8.3 Hubei Widely Chemical Technology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hubei Widely Chemical Technology Main Business Overview
13.8.5 Hubei Widely Chemical Technology Latest Developments
13.9 Hubei Xingcheng Biotechnology
13.9.1 Hubei Xingcheng Biotechnology Company Information
13.9.2 Hubei Xingcheng Biotechnology Secukinumab Product Offered
13.9.3 Hubei Xingcheng Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hubei Xingcheng Biotechnology Main Business Overview
13.9.5 Hubei Xingcheng Biotechnology Latest Developments
13.10 Hubei Zhongshan Medical Technology
13.10.1 Hubei Zhongshan Medical Technology Company Information
13.10.2 Hubei Zhongshan Medical Technology Secukinumab Product Offered
13.10.3 Hubei Zhongshan Medical Technology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Hubei Zhongshan Medical Technology Main Business Overview
13.10.5 Hubei Zhongshan Medical Technology Latest Developments
13.11 Jiangxi Ruiweier Biotechnology
13.11.1 Jiangxi Ruiweier Biotechnology Company Information
13.11.2 Jiangxi Ruiweier Biotechnology Secukinumab Product Offered
13.11.3 Jiangxi Ruiweier Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jiangxi Ruiweier Biotechnology Main Business Overview
13.11.5 Jiangxi Ruiweier Biotechnology Latest Developments
13.12 Nantong Hi-Future Biotechnology
13.12.1 Nantong Hi-Future Biotechnology Company Information
13.12.2 Nantong Hi-Future Biotechnology Secukinumab Product Offered
13.12.3 Nantong Hi-Future Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Nantong Hi-Future Biotechnology Main Business Overview
13.12.5 Nantong Hi-Future Biotechnology Latest Developments
13.13 Shanghai Biochempartner
13.13.1 Shanghai Biochempartner Company Information
13.13.2 Shanghai Biochempartner Secukinumab Product Offered
13.13.3 Shanghai Biochempartner Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Biochempartner Main Business Overview
13.13.5 Shanghai Biochempartner Latest Developments
13.14 Shanghai Minkai Biotechnology
13.14.1 Shanghai Minkai Biotechnology Company Information
13.14.2 Shanghai Minkai Biotechnology Secukinumab Product Offered
13.14.3 Shanghai Minkai Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Shanghai Minkai Biotechnology Main Business Overview
13.14.5 Shanghai Minkai Biotechnology Latest Developments
13.15 Shanghai Yifei Biotechnology
13.15.1 Shanghai Yifei Biotechnology Company Information
13.15.2 Shanghai Yifei Biotechnology Secukinumab Product Offered
13.15.3 Shanghai Yifei Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shanghai Yifei Biotechnology Main Business Overview
13.15.5 Shanghai Yifei Biotechnology Latest Developments
13.16 Shanghai Yu'ang Chemical
13.16.1 Shanghai Yu'ang Chemical Company Information
13.16.2 Shanghai Yu'ang Chemical Secukinumab Product Offered
13.16.3 Shanghai Yu'ang Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shanghai Yu'ang Chemical Main Business Overview
13.16.5 Shanghai Yu'ang Chemical Latest Developments
13.17 Sichuan Weiqi Biotechnology
13.17.1 Sichuan Weiqi Biotechnology Company Information
13.17.2 Sichuan Weiqi Biotechnology Secukinumab Product Offered
13.17.3 Sichuan Weiqi Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sichuan Weiqi Biotechnology Main Business Overview
13.17.5 Sichuan Weiqi Biotechnology Latest Developments
13.18 Taizhou KEDE Chemical
13.18.1 Taizhou KEDE Chemical Company Information
13.18.2 Taizhou KEDE Chemical Secukinumab Product Offered
13.18.3 Taizhou KEDE Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Taizhou KEDE Chemical Main Business Overview
13.18.5 Taizhou KEDE Chemical Latest Developments
13.19 WeiShi Reagent
13.19.1 WeiShi Reagent Company Information
13.19.2 WeiShi Reagent Secukinumab Product Offered
13.19.3 WeiShi Reagent Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 WeiShi Reagent Main Business Overview
13.19.5 WeiShi Reagent Latest Developments
13.20 Wuhan Dingxintong Pharmaceutical
13.20.1 Wuhan Dingxintong Pharmaceutical Company Information
13.20.2 Wuhan Dingxintong Pharmaceutical Secukinumab Product Offered
13.20.3 Wuhan Dingxintong Pharmaceutical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Wuhan Dingxintong Pharmaceutical Main Business Overview
13.20.5 Wuhan Dingxintong Pharmaceutical Latest Developments
13.21 Wuhan Fortuna Chemical
13.21.1 Wuhan Fortuna Chemical Company Information
13.21.2 Wuhan Fortuna Chemical Secukinumab Product Offered
13.21.3 Wuhan Fortuna Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Wuhan Fortuna Chemical Main Business Overview
13.21.5 Wuhan Fortuna Chemical Latest Developments
13.22 Wuhan Topule Biopharmaceutical
13.22.1 Wuhan Topule Biopharmaceutical Company Information
13.22.2 Wuhan Topule Biopharmaceutical Secukinumab Product Offered
13.22.3 Wuhan Topule Biopharmaceutical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Wuhan Topule Biopharmaceutical Main Business Overview
13.22.5 Wuhan Topule Biopharmaceutical Latest Developments
13.23 Wuhan Weisman Bioengineering
13.23.1 Wuhan Weisman Bioengineering Company Information
13.23.2 Wuhan Weisman Bioengineering Secukinumab Product Offered
13.23.3 Wuhan Weisman Bioengineering Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Wuhan Weisman Bioengineering Main Business Overview
13.23.5 Wuhan Weisman Bioengineering Latest Developments
13.24 Wuhan Yingnuo Pharmaceutical Technology
13.24.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
13.24.2 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product Offered
13.24.3 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview
13.24.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments
14 Research Findings and Conclusion
Table 1. Secukinumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Secukinumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Secukinumab Sales by Type (2017-2022) & (Kg)
Table 6. Global Secukinumab Sales Market Share by Type (2017-2022)
Table 7. Global Secukinumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Secukinumab Revenue Market Share by Type (2017-2022)
Table 9. Global Secukinumab Sale Price by Type (2017-2022) & (US$/Kg)
Table 10. Global Secukinumab Sales by Application (2017-2022) & (Kg)
Table 11. Global Secukinumab Sales Market Share by Application (2017-2022)
Table 12. Global Secukinumab Revenue by Application (2017-2022)
Table 13. Global Secukinumab Revenue Market Share by Application (2017-2022)
Table 14. Global Secukinumab Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Secukinumab Sales by Company (2020-2022) & (Kg)
Table 16. Global Secukinumab Sales Market Share by Company (2020-2022)
Table 17. Global Secukinumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Secukinumab Revenue Market Share by Company (2020-2022)
Table 19. Global Secukinumab Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Secukinumab Producing Area Distribution and Sales Area
Table 21. Players Secukinumab Products Offered
Table 22. Secukinumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Secukinumab Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Secukinumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Secukinumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Secukinumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Secukinumab Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Secukinumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Secukinumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Secukinumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Secukinumab Sales by Country (2017-2022) & (Kg)
Table 34. Americas Secukinumab Sales Market Share by Country (2017-2022)
Table 35. Americas Secukinumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Secukinumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Secukinumab Sales by Type (2017-2022) & (Kg)
Table 38. Americas Secukinumab Sales Market Share by Type (2017-2022)
Table 39. Americas Secukinumab Sales by Application (2017-2022) & (Kg)
Table 40. Americas Secukinumab Sales Market Share by Application (2017-2022)
Table 41. APAC Secukinumab Sales by Region (2017-2022) & (Kg)
Table 42. APAC Secukinumab Sales Market Share by Region (2017-2022)
Table 43. APAC Secukinumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Secukinumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Secukinumab Sales by Type (2017-2022) & (Kg)
Table 46. APAC Secukinumab Sales Market Share by Type (2017-2022)
Table 47. APAC Secukinumab Sales by Application (2017-2022) & (Kg)
Table 48. APAC Secukinumab Sales Market Share by Application (2017-2022)
Table 49. Europe Secukinumab Sales by Country (2017-2022) & (Kg)
Table 50. Europe Secukinumab Sales Market Share by Country (2017-2022)
Table 51. Europe Secukinumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Secukinumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Secukinumab Sales by Type (2017-2022) & (Kg)
Table 54. Europe Secukinumab Sales Market Share by Type (2017-2022)
Table 55. Europe Secukinumab Sales by Application (2017-2022) & (Kg)
Table 56. Europe Secukinumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Secukinumab Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Secukinumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Secukinumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Secukinumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Secukinumab Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Secukinumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Secukinumab Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Secukinumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Secukinumab
Table 66. Key Market Challenges & Risks of Secukinumab
Table 67. Key Industry Trends of Secukinumab
Table 68. Secukinumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Secukinumab Distributors List
Table 71. Secukinumab Customer List
Table 72. Global Secukinumab Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Secukinumab Sales Market Forecast by Region
Table 74. Global Secukinumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Secukinumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Secukinumab Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Secukinumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Secukinumab Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Secukinumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Secukinumab Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Secukinumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Secukinumab Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Secukinumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Secukinumab Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Secukinumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Secukinumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Secukinumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Secukinumab Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Secukinumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Secukinumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Secukinumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. Carbosynth Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 93. Carbosynth Secukinumab Product Offered
Table 94. Carbosynth Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Carbosynth Main Business
Table 96. Carbosynth Latest Developments
Table 97. TargetMol Chemicals Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 98. TargetMol Chemicals Secukinumab Product Offered
Table 99. TargetMol Chemicals Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. TargetMol Chemicals Main Business
Table 101. TargetMol Chemicals Latest Developments
Table 102. Changzhou Chenhong Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 103. Changzhou Chenhong Biotechnology Secukinumab Product Offered
Table 104. Changzhou Chenhong Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Changzhou Chenhong Biotechnology Main Business
Table 106. Changzhou Chenhong Biotechnology Latest Developments
Table 107. DC Chemicals Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 108. DC Chemicals Secukinumab Product Offered
Table 109. DC Chemicals Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. DC Chemicals Main Business
Table 111. DC Chemicals Latest Developments
Table 112. Huatesheng Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Huatesheng Biotechnology Secukinumab Product Offered
Table 114. Huatesheng Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Huatesheng Biotechnology Main Business
Table 116. Huatesheng Biotechnology Latest Developments
Table 117. Hubei Guangao Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Hubei Guangao Biotechnology Secukinumab Product Offered
Table 119. Hubei Guangao Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Hubei Guangao Biotechnology Main Business
Table 121. Hubei Guangao Biotechnology Latest Developments
Table 122. Hubei Kele Fine Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Hubei Kele Fine Chemical Secukinumab Product Offered
Table 124. Hubei Kele Fine Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Hubei Kele Fine Chemical Main Business
Table 126. Hubei Kele Fine Chemical Latest Developments
Table 127. Hubei Widely Chemical Technology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Hubei Widely Chemical Technology Secukinumab Product Offered
Table 129. Hubei Widely Chemical Technology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Hubei Widely Chemical Technology Main Business
Table 131. Hubei Widely Chemical Technology Latest Developments
Table 132. Hubei Xingcheng Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Hubei Xingcheng Biotechnology Secukinumab Product Offered
Table 134. Hubei Xingcheng Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Hubei Xingcheng Biotechnology Main Business
Table 136. Hubei Xingcheng Biotechnology Latest Developments
Table 137. Hubei Zhongshan Medical Technology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 138. Hubei Zhongshan Medical Technology Secukinumab Product Offered
Table 139. Hubei Zhongshan Medical Technology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Hubei Zhongshan Medical Technology Main Business
Table 141. Hubei Zhongshan Medical Technology Latest Developments
Table 142. Jiangxi Ruiweier Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangxi Ruiweier Biotechnology Secukinumab Product Offered
Table 144. Jiangxi Ruiweier Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Jiangxi Ruiweier Biotechnology Main Business
Table 146. Jiangxi Ruiweier Biotechnology Latest Developments
Table 147. Nantong Hi-Future Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 148. Nantong Hi-Future Biotechnology Secukinumab Product Offered
Table 149. Nantong Hi-Future Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 150. Nantong Hi-Future Biotechnology Main Business
Table 151. Nantong Hi-Future Biotechnology Latest Developments
Table 152. Shanghai Biochempartner Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Biochempartner Secukinumab Product Offered
Table 154. Shanghai Biochempartner Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 155. Shanghai Biochempartner Main Business
Table 156. Shanghai Biochempartner Latest Developments
Table 157. Shanghai Minkai Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 158. Shanghai Minkai Biotechnology Secukinumab Product Offered
Table 159. Shanghai Minkai Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 160. Shanghai Minkai Biotechnology Main Business
Table 161. Shanghai Minkai Biotechnology Latest Developments
Table 162. Shanghai Yifei Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 163. Shanghai Yifei Biotechnology Secukinumab Product Offered
Table 164. Shanghai Yifei Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 165. Shanghai Yifei Biotechnology Main Business
Table 166. Shanghai Yifei Biotechnology Latest Developments
Table 167. Shanghai Yu'ang Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 168. Shanghai Yu'ang Chemical Secukinumab Product Offered
Table 169. Shanghai Yu'ang Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 170. Shanghai Yu'ang Chemical Main Business
Table 171. Shanghai Yu'ang Chemical Latest Developments
Table 172. Sichuan Weiqi Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 173. Sichuan Weiqi Biotechnology Secukinumab Product Offered
Table 174. Sichuan Weiqi Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 175. Sichuan Weiqi Biotechnology Main Business
Table 176. Sichuan Weiqi Biotechnology Latest Developments
Table 177. Taizhou KEDE Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 178. Taizhou KEDE Chemical Secukinumab Product Offered
Table 179. Taizhou KEDE Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 180. Taizhou KEDE Chemical Main Business
Table 181. Taizhou KEDE Chemical Latest Developments
Table 182. WeiShi Reagent Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 183. WeiShi Reagent Secukinumab Product Offered
Table 184. WeiShi Reagent Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 185. WeiShi Reagent Main Business
Table 186. WeiShi Reagent Latest Developments
Table 187. Wuhan Dingxintong Pharmaceutical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 188. Wuhan Dingxintong Pharmaceutical Secukinumab Product Offered
Table 189. Wuhan Dingxintong Pharmaceutical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 190. Wuhan Dingxintong Pharmaceutical Main Business
Table 191. Wuhan Dingxintong Pharmaceutical Latest Developments
Table 192. Wuhan Fortuna Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 193. Wuhan Fortuna Chemical Secukinumab Product Offered
Table 194. Wuhan Fortuna Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 195. Wuhan Fortuna Chemical Main Business
Table 196. Wuhan Fortuna Chemical Latest Developments
Table 197. Wuhan Topule Biopharmaceutical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 198. Wuhan Topule Biopharmaceutical Secukinumab Product Offered
Table 199. Wuhan Topule Biopharmaceutical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 200. Wuhan Topule Biopharmaceutical Main Business
Table 201. Wuhan Topule Biopharmaceutical Latest Developments
Table 202. Wuhan Weisman Bioengineering Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 203. Wuhan Weisman Bioengineering Secukinumab Product Offered
Table 204. Wuhan Weisman Bioengineering Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 205. Wuhan Weisman Bioengineering Main Business
Table 206. Wuhan Weisman Bioengineering Latest Developments
Table 207. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors
Table 208. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product Offered
Table 209. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 210. Wuhan Yingnuo Pharmaceutical Technology Main Business
Table 211. Wuhan Yingnuo Pharmaceutical Technology Latest Developments
List of Figures
Figure 1. Picture of Secukinumab
Figure 2. Secukinumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Secukinumab Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Secukinumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Secukinumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Secukinumab Sales Market Share by Type in 2021
Figure 12. Global Secukinumab Revenue Market Share by Type (2017-2022)
Figure 13. Secukinumab Consumed in Chemical
Figure 14. Global Secukinumab Market: Chemical (2017-2022) & (Kg)
Figure 15. Secukinumab Consumed in Pharmaceutical
Figure 16. Global Secukinumab Market: Pharmaceutical (2017-2022) & (Kg)
Figure 17. Global Secukinumab Sales Market Share by Application (2017-2022)
Figure 18. Global Secukinumab Revenue Market Share by Application in 2021
Figure 19. Secukinumab Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Secukinumab Revenue Market Share by Company in 2021
Figure 21. Global Secukinumab Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Secukinumab Revenue Market Share by Geographic Region in 2021
Figure 23. Global Secukinumab Sales Market Share by Region (2017-2022)
Figure 24. Global Secukinumab Revenue Market Share by Country/Region in 2021
Figure 25. Americas Secukinumab Sales 2017-2022 (Kg)
Figure 26. Americas Secukinumab Revenue 2017-2022 ($ Millions)
Figure 27. APAC Secukinumab Sales 2017-2022 (Kg)
Figure 28. APAC Secukinumab Revenue 2017-2022 ($ Millions)
Figure 29. Europe Secukinumab Sales 2017-2022 (Kg)
Figure 30. Europe Secukinumab Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Secukinumab Sales 2017-2022 (Kg)
Figure 32. Middle East & Africa Secukinumab Revenue 2017-2022 ($ Millions)
Figure 33. Americas Secukinumab Sales Market Share by Country in 2021
Figure 34. Americas Secukinumab Revenue Market Share by Country in 2021
Figure 35. United States Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Secukinumab Sales Market Share by Region in 2021
Figure 40. APAC Secukinumab Revenue Market Share by Regions in 2021
Figure 41. China Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Secukinumab Sales Market Share by Country in 2021
Figure 48. Europe Secukinumab Revenue Market Share by Country in 2021
Figure 49. Germany Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Secukinumab Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Secukinumab Revenue Market Share by Country in 2021
Figure 56. Egypt Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Secukinumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Secukinumab in 2021
Figure 62. Manufacturing Process Analysis of Secukinumab
Figure 63. Industry Chain Structure of Secukinumab
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...